Probiotix Health PLC - Distribution agreement
Announcement provided by
ProBiotix Health Plc · PBX01/08/2023 07:00
ProBiotix Health plc
("ProBiotix" or the "Company")
Distribution agreement
Distribution of finished turnkey products in
ProBiotix Health plc (AQSE: PBX), a life sciences business developing probiotics to tackle lifestyle conditions such as cardiovascular disease, announces that the Company has signed an exclusive distribution agreement with Trans Chem to cover the Australian and
Trans Chem is one of
Steen Andersen, CEO of ProBiotix Health plc commented: "We are delighted to have signed this agreement with Trans Chem, which will further enhance our global reach. Although our primary strategic focus is on developing the European and North American markets, we believe that there is a significant business potential in
"Trans Chem is a leading distributor in the region and will be responsible for selling our finished turn-key product solutions based on LPLDL® into the leading brands in the regions. The finished turn-key product solutions will be manufactured through local Australian and
For further information, please contact:
ProBiotix Health plc |
|
Steen Andersen, Chief Executive |
Contact via Walbrook below |
|
|
Peterhouse Capital Ltd (AQSE Corporate Adviser and Broker) |
Tel: 020 7469 0930 |
Mark Anwyl |
|
Duncan Vasey |
|
|
|
Walbrook PR Ltd |
probiotix@walbrookpr.com |
Anna Dunphy |
Mob: 07876 741 001 |
Market Abuse Regulation (MAR) Disclosure
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law (as defined in the European Union (Withdrawal) Act 2018).
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.